LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 332 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $796,000 | -10.9% | 9,239 | -7.7% | 0.01% | -11.1% |
Q2 2022 | $893,000 | -54.2% | 10,007 | -42.2% | 0.01% | -57.1% |
Q1 2022 | $1,949,000 | -34.8% | 17,324 | -10.4% | 0.02% | -38.2% |
Q4 2021 | $2,987,000 | +4.9% | 19,340 | -5.4% | 0.03% | +25.9% |
Q3 2021 | $2,847,000 | -0.6% | 20,434 | -6.4% | 0.03% | +8.0% |
Q2 2021 | $2,863,000 | -35.4% | 21,824 | -25.0% | 0.02% | -41.9% |
Q1 2021 | $4,434,000 | +53.4% | 29,085 | +0.1% | 0.04% | +30.3% |
Q4 2020 | $2,890,000 | +47.9% | 29,060 | +41.8% | 0.03% | +13.8% |
Q3 2020 | $1,954,000 | -20.2% | 20,500 | -6.4% | 0.03% | -12.1% |
Q2 2020 | $2,449,000 | +12.2% | 21,898 | -27.0% | 0.03% | -2.9% |
Q1 2020 | $2,182,000 | -40.8% | 30,011 | -15.1% | 0.03% | +17.2% |
Q4 2019 | $3,687,000 | -2.3% | 35,352 | -6.8% | 0.03% | 0.0% |
Q3 2019 | $3,775,000 | -25.2% | 37,928 | -14.3% | 0.03% | -21.6% |
Q2 2019 | $5,049,000 | -24.1% | 44,232 | -16.4% | 0.04% | -21.3% |
Q1 2019 | $6,655,000 | -3.6% | 52,937 | +4.1% | 0.05% | -13.0% |
Q4 2018 | $6,900,000 | -35.8% | 50,847 | +29.9% | 0.05% | -23.9% |
Q3 2018 | $10,748,000 | +68.5% | 39,156 | +27.2% | 0.07% | +69.0% |
Q2 2018 | $6,378,000 | +36.4% | 30,784 | +8.8% | 0.04% | +13.5% |
Q1 2018 | $4,675,000 | +46.0% | 28,305 | +21.0% | 0.04% | +68.2% |
Q4 2017 | $3,202,000 | +14.2% | 23,386 | +13.5% | 0.02% | +10.0% |
Q3 2017 | $2,805,000 | +22.4% | 20,603 | +9.1% | 0.02% | +25.0% |
Q2 2017 | $2,292,000 | +20.7% | 18,883 | +5.3% | 0.02% | +23.1% |
Q1 2017 | $1,899,000 | -7.0% | 17,941 | -10.7% | 0.01% | -13.3% |
Q4 2016 | $2,041,000 | -24.8% | 20,084 | -24.5% | 0.02% | -31.8% |
Q3 2016 | $2,713,000 | -31.7% | 26,586 | -20.2% | 0.02% | -37.1% |
Q2 2016 | $3,974,000 | +38.6% | 33,320 | +24.4% | 0.04% | +16.7% |
Q1 2016 | $2,867,000 | -15.5% | 26,775 | -14.4% | 0.03% | -9.1% |
Q4 2015 | $3,393,000 | -89.1% | 31,294 | -13.6% | 0.03% | 0.0% |
Q3 2015 | $31,024,000 | +1053.7% | 36,222 | +35.9% | 0.03% | +43.5% |
Q2 2015 | $2,689,000 | +107.2% | 26,651 | +58.4% | 0.02% | +109.1% |
Q1 2015 | $1,298,000 | +99.7% | 16,828 | +60.4% | 0.01% | +57.1% |
Q4 2013 | $650,000 | +179.0% | 10,494 | +94.9% | 0.01% | +133.3% |
Q3 2013 | $233,000 | – | 5,384 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |